Patients who developed IRIS presented more often with a symptomatic WHO stage compared to patients who did not, had lower baseline CD4 counts, lower eosinophil counts and were more often diagnosed with active TB at baseline (Table 1). The gene discussed is CD4; the disease is tuberculosis.